WikiMD is world's largest health encyclopedia with
28,544 pages, 3,991,367 edits & 34,287,015 views.
Sonidegib
Sonidegib (INN) or erismodegib (USAN), also known as LDE225, is a Hedgehog signaling pathway inhibitor (via smoothened antagonism) being developed as an anticancer agent by Novartis.[1][2] It has been investigated as a potential treatment for:
- Pancreatic cancer[3][4][5][6]
- Breast cancer[7][8]
- Basal cell carcinoma of the skin[9][10][11]
- Small cell lung cancer[12]
- Medulloblastoma[13][14]
- Advanced solid tumours (including ovarian, breast, pancreatic, stomach, oesophageal cancers and glioblastoma multiforme)[15][16][17]
- Acute leukaemia[18]
- Chronic myeloid leukaemia[19]
- Myelofibrosis and essential thrombocythaemia[20]
It has demonstrated significant efficacy against melanoma in vitro and in vivo.[21] It also demonstrated efficacy in a mouse model of pancreatic cancer.[22]
Reference list
Alphabetic list of antineoplastic agents - 0-9 - A1 - A2 - A3 - A4 - A5 -A6 - B - C - D - E - F - G - H - I - JK - L - M - NO - PQ - R - S - T - UVW - XYZ
Learn more about Sonidegib
Latest research (Pubmed)
External links
WikiMD needs you!
This WikiMD article Sonidegib is a stub.
If you are a healthcare professional familiar with the topic Sonidegib, or
A subject matter expert or authority on Sonidegib, you can help us.
About | Mission | Paid editors welcome!
Sonidegib is part of WikiMD's Physician reviewed^ articles available 4free, 4all, 4ever! |
---|
Medicine: Health - Encyclopedia - Topics - Diseases - Cancer - Rare diseases - Random Page Navigation: Drugs - Wellness - Obesity - Diet - Ketogenic diet - W8MD weight loss diet - Editors: Recently Edited Pages - Alphabetical Order - Sponsors - USMLE The content on or accessible through WikiMD is for informational purposes only. WikiMD is not a substitute for professional medical advice. ^See full Disclaimers |
Ad. Tired of being overweight?. W8MD's insurance Weight loss program can HELP* |